Vickers Vantage Corp I (VCKA) Signs LoI with Scilex Holding

Vickers Vantage I (NASDAQ:VCKA) announced a “teaser” this morning noting that it has signed a letter-of-intent (LOI) to combine with biotech firm Scilex at a proposed equity valuation of $1.5 billion. Scilex is a subsidiary of San Diego, California-based Sorrento Therapeutics (NASDAQ:SRNE) that is working to develop a line of non-opioid pain management products. This
Read More